Evidence map›Paper›PMID 32413313›Full record

ArticleBiophysical journal2020

Structural and Hydrodynamic Characterization of Dimeric Human Oligoadenylate Synthetase 2.

Amit Koul, Danielle Gemmill, Nikhat Lubna, Markus Meier, Natalie Krahn, Evan P Booy, Jörg Stetefeld, Trushar R Patel, Sean A McKenna

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Biophysical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. A CRISPR-Cas9 knockout screening identifies IRF2 as a key driver of OAS3/RNase L-mediated RNA decay during viral infection.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Amit KoulDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada.
Danielle GemmillAlberta RNA Research and Training Institute, Department of Chemistry and Biochemistry, University of Lethbridge, Lethbridge, Alberta, Canada.
Nikhat LubnaDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada.
Markus MeierDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada.
Natalie KrahnDepartment of Molecular Biology and Biochemistry, Yale University, New Haven, Connecticut.
Evan P BooyDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada.
Jörg StetefeldDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada.
Trushar R PatelAlberta RNA Research and Training Institute, Department of Chemistry and Biochemistry, University of Lethbridge, Lethbridge, Alberta, Canada; Department of Microbiology, Immunology and Infectious Disease, Cumming School of Medicine, University of Calgary, Northwest Calgary, Alberta, Canada; Li Ka Shing Institute of Virology and Discovery Lab, University of Alberta, Edmonton, Alberta, Canada. Electronic address: trushar.patel@uleth.ca.
Sean A McKennaDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada. Electronic address: sean.mckenna@umanitoba.ca.
University of Manitoba · CAUniversity of Lethbridge · CAYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oligoadenylate synthetases (OASs) are a family of interferon-inducible enzymes that require double-stranded RNA (dsRNA) as a cofactor. Upon binding dsRNA, OAS undergoes a conformational change and is activated to polymerize ATP into 2'-5'-oligoadenylate chains. The OAS family consists of several isozymes, with unique domain organizations to potentially interact with dsRNA of variable length, providing diversity in viral RNA recognition. In addition, oligomerization of OAS isozymes, potentially OAS1 and OAS2, is hypothesized to be important for 2'-5'-oligoadenylate chain building. In this study, we present the solution conformation of dimeric human OAS2 using an integrated approach involving small-angle x-ray scattering, analytical ultracentrifugation, and dynamic light scattering techniques. We also demonstrate OAS2 dimerization using immunoprecipitation approaches in human cells. Whereas mutation of a key active-site aspartic acid residue prevents OAS2 activity, a C-terminal mutation previously hypothesized to disrupt OAS self-association had only a minor effect on OAS2 activity. Finally, we also present the solution structure of OAS1 monomer and dimer, comparing their hydrodynamic properties with OAS2. In summary, our work presents the first, to our knowledge, dimeric structural models of OAS2 that enhance our understanding of the oligomerization and catalytic function of OAS enzymes.

Indexed as

2',5'-Oligoadenylate SynthetaseLigasesAdenine NucleotidesHumansHydrodynamicsOligoribonucleotidesRNA, Double-Stranded2',5'-oligoadenylate2',5'-Oligoadenylate SynthetaseAdenine NucleotidesLigasesOAS2 protein, humanOligoribonucleotidesRNA, Double-Stranded

Identifiers

PMID32413313
PMCPMC7264852
OpenAlexW3023745098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.